We are live on ! Find out more
KLCMU

Kite Lake Capital Management (UK) Portfolio holdings

AUM $290M
1-Year Est. Return 183.72%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+183.72%
3 Year Est. Return
+337.34%
5 Year Est. Return
+421.47%
10 Year Est. Return
AUM
$1.92B
AUM Growth
+$366M
Cap. Flow
-$33.1M
Cap. Flow %
-1.73%
Top 10 Hldgs %
99.93%
Holding
17
New
4
Increased
6
Reduced
Closed
6

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.18%
2 Communication Services 10.22%
3 Healthcare 5.1%
4 Consumer Discretionary 3.9%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$1.42B 74.01%
482,300
+114,800
+31% +$33.1M
RHT
2
DELISTED
Red Hat Inc
RHT
$148M 7.74%
789,782
+333,275
+73% +$61.5M
BA icon
3
PUT
Boeing
BA
$160B
$105M 5.48%
288,600
WBC
4
DELISTED
WABCO HOLDINGS INC.
WBC
$74.8M 3.9%
564,059
+369,795
+190% +$48.8M
TRCO
5
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$47.6M 2.48%
1,029,039
+29,774
+3% +$1.38M
ARRY
6
DELISTED
Array Biopharma Inc
ARRY
$40.2M 2.1%
+867,600
New +$24.4M
ONCE
7
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$36.3M 1.89%
+354,658
New +$38.3M
PACB icon
8
Pacific Biosciences
PACB
$417M
$21.2M 1.11%
3,503,293
+923,272
+36% +$6.47M
OXY icon
9
PUT
Occidental Petroleum
OXY
$59.3B
$13.3M 0.7%
+265,100
New +$14.9M
VSM
10
DELISTED
Versum Materials, Inc.
VSM
$10.2M 0.53%
197,971
+4,810
+2% +$248K
FDC
11
DELISTED
First Data Corporation
FDC
$1.33M 0.07%
+49,153
New +$1.28M
BMY icon
12
Bristol-Myers Squibb
BMY
$130B
-2,335,800
Closed -$110M
FOXA icon
13
Fox Class A
FOXA
$27.8B
-97,162
Closed -$3.57M
ULTI
14
DELISTED
Ultimate Software Group Inc
ULTI
-38,440
Closed -$12.7M
USG
15
DELISTED
Usg
USG
-569,554
Closed -$24.7M
CMTA
16
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
-836,070
Closed -$21.8M
CELG
17
DELISTED
Celgene Corp
CELG
-447,200
Closed -$42.2M

Similar funds

Kite Lake Capital Management (UK)'s Q2 2019 Portfolio in Review

As of Q2 2019, Kite Lake Capital Management (UK) held 17 positions worth $1.92B, up 24% from $1.55B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Kite Lake Capital Management (UK)'s Q2 2019 filing shows 4 new, 6 increased and 6 closed positions. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 354,658 shares worth $36.3M. The largest sale was Bristol-Myers Squibb, an estimated $110M.

By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, up from 74% a quarter earlier, followed by Communication Services and Healthcare.

  • Kite Lake Capital Management (UK)'s largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 354,658 shares worth $36.3M.
  • Kite Lake Capital Management (UK) added most to Red Hat Inc in Q2 2019, an estimated $61.5M increase.
  • Kite Lake Capital Management (UK) fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $110M.
  • Kite Lake Capital Management (UK)'s ten largest holdings make up 100% of its $1.92B portfolio in Q2 2019.
  • Kite Lake Capital Management (UK) opened 4 new positions and closed 6 in Q2 2019.
  • Kite Lake Capital Management (UK)'s portfolio value rose 24% quarter-over-quarter to $1.92B.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q2 2019, filed 14 Aug 2019.